Merit Medical Systems (MMSI) vs Envista (NVST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Envista (NVST) has outperformed Merit Medical Systems (MMSI) over the past year, gaining 10.4% versus a gain of 1.8%. Over five years, MMSI leads with a +22.5% price change compared with -41.3% for NVST. Merit Medical Systems is the larger company by market cap ($5.09 billion vs $3.65 billion), about 1.4 times the size.
On valuation, Envista trades at a lower forward P/E (13.7x vs 18.5x for Merit Medical Systems). Merit Medical Systems converts more of its revenue into profit, with a net margin of 8.5% versus 1.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MMSI | NVST |
|---|---|---|
| Share price | $85.25 | $22.72 |
| Market cap | $5.09B | $3.65B |
| 1-day change | +0.19% | -1.39% |
| YTD return | -3.28% | +4.65% |
| 1-year return | +1.80% | +10.40% |
| 5-year return | +22.50% | -41.32% |
| P/E ratio (TTM) | 35.08 | 39.17 |
| Forward P/E | 18.49 | 13.65 |
| EPS (TTM) | $2.43 | $0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.52B | $2.72B |
| Revenue growth (YoY) | +11.75% | +8.32% |
| Net income (latest FY) | $128.49M | $47.00M |
| Gross margin | 48.70% | 54.67% |
| Operating margin | 12.19% | 7.95% |
| Net margin | 8.48% | 1.73% |
| 52-week high | $94.75 | $30.42 |
| 52-week low | $59.74 | $18.77 |
| Distance from 52-week high | -10.03% | -25.31% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +19.00% | +30.68% |
| Average volume | 796.95K | 2.77M |
| Shares outstanding | 59.71M | 160.62M |
| Employees | 7,500 | 12,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Merit Medical Systems is more profitable, keeping 8.5 cents of every revenue dollar as net income versus 1.7 cents for Envista.
About Merit Medical Systems
MMSI stock →Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.
Health Care · Medical/Dental Instruments · 7,500 employees
About Envista
NVST stock →Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
Health Care · Medical/Dental Instruments · 12,000 employees
MMSI vs NVST FAQ
Which is bigger, Merit Medical Systems or Envista?
Merit Medical Systems (MMSI) is larger, with a market capitalization of $5.09B compared with $3.65B for Envista (NVST).
Which stock has performed better over the past year, MMSI or NVST?
NVST returned +10.40% over the past 12 months, compared with +1.80% for MMSI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, MMSI or NVST?
MMSI has the lower trailing P/E at 35.1, versus 39.2 for NVST. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Merit Medical Systems and Envista in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.